ClinicalTrials.gg
Sign In

Carcinoma, Large Cell clinical trials

The registry lists 20 studies for Carcinoma, Large Cell across more than 10 countries. 1 are recruiting or about to start. 2 of them are mainly about Carcinoma, Large Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-16.

Get an email when these change. Save the Carcinoma, Large Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
9
Terminated
6
Active, not recruiting
1
No longer available
1
Status unknown
1
Withdrawn
1

Phase

Phase 2
7
Phase 1
5
Phase 3
5
Phase 4
2

Where

United States
15
Taiwan
7
Korea, Republic of
6
Spain
4
Hungary
4
Italy
4

Who runs them

Maia Biotechnology (2) · Pfizer (2) · Ariad Pharmaceuticals (2) · Pharmacyclics LLC. (2) · Creative Biosciences (Guangzhou) Co., Ltd. (1) · Infinity Pharmaceuticals, Inc. (1) · NewLink Genetics Corporation (1) · M.D. Anderson Cancer Center (1)

What is being tested here

Drugs under test in Carcinoma, Large Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Alpha-2'-deoxythioguanosine112
Cemiplimab111
Docetaxel002
Figitumumab022
Brigatinib011
Albumin-Bound Paclitaxel001
Paclitaxel001
Carboplatin001
Vandetanib011
Everolimus001

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 · Antimitotic agents 3

Coming up

1phase 3 study under way
2studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2, phase 3 first

Who these studies take

Of the 1 Carcinoma, Large Cell studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 1
AgeWomenMen
100 (0%)0 (0%)
181 (100%)1 (100%)
301 (100%)1 (100%)
401 (100%)1 (100%)
501 (100%)1 (100%)
651 (100%)1 (100%)
751 (100%)1 (100%)
851 (100%)1 (100%)

Across all 20 studies, recruiting or not: 5% stop at 75 or younger and 5% at 65; 5% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.